Positron Emitting Activity
- Name
- Positron Emitting Activity
- Accession Number
- DBCAT004201
- Description
Not Available
- Drugs
Drug Drug Description Florbetapir (18F) A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment. Florbetaben F-18 A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment. Dotatate gallium Ga-68 Dotatate gallium 68 is one of the most prominent radiopharmaceuticals used in imaging with positron emission tomography. It binds to the somatostatin-2 receptor which is usually overexpressed in many neuroendocrine... Fluciclovine (18F) A radiolabelled L-leucine derivative used to image tumors, especially in the prostate. Copper oxodotreotide Cu-64 A Cu labeled somatostatin analog used in positron emission tomography to detect certain types of neuroendocrine tumors. Piflufolastat F 18 A radiopharmaceutical diagnostic agent used with PET to image PSMA-positive lesions for the diagnosis of metastatic or recurrent prostate cancer. Fluoroestradiol F-18 A radiolabeled analog of estradiol used as a contrast agent in the PET imaging of estrogen receptor-positive breast cancer lesions. Gallium Ga-68 gozetotide A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography. Flotufolastat F-18 A radiopharmaceutical diagnostic agent used in PET imaging to visualize PSMA-positive lesions in men with prostate cancer with suspected metastasis or recurrence. - Drugs & Drug Targets